CytoDyn (CYDY) Interest Coverage Ratio Growth (3y) (2013 - 2026)
CytoDyn (CYDY) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | -106.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -106.18% |
| Nov 30, 2025 | 6.29% |
| Aug 31, 2025 | -23.69% |
| May 31, 2025 | 86.67% |
| Feb 28, 2025 | -58.10% |
| Nov 30, 2024 | -22.99% |
| Aug 31, 2024 | 184.78% |
| May 31, 2024 | -41.35% |
| Feb 29, 2024 | 13.16% |
| Nov 30, 2023 | -17.10% |
| Aug 31, 2023 | 7.43% |
| May 31, 2023 | 59.51% |
| Feb 28, 2023 | 41.08% |
| Nov 30, 2022 | -19.08% |
| Aug 31, 2022 | 34.32% |
| May 31, 2022 | -192.58% |
| Feb 28, 2022 | 58.34% |
| Nov 30, 2021 | 42.62% |
| Aug 31, 2021 | 71.28% |
| May 31, 2021 | 73.84% |